Literature DB >> 2943285

Bile flow decrease and altered bile composition in streptozotocin-treated rats.

C E Carnovale, R A Marinelli, E A Rodríguez Garay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2943285     DOI： 10.1016/0006-2952(86)90063-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Effect of acute insulin administration on biliary lipid secretion by the diabetic rat.

Authors:  G R Villanueva; M Herreros; F Perez-Barriocanal; E Fernandez; J J Marin
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

3.  Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.

Authors:  Yu C Kim; Joo H Lee; So H Kim; Myung G Lee
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 4.  Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-03-06       Impact factor: 2.441

5.  Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.

Authors:  A S Arboatti; F Lambertucci; M G Sedlmeier; G Pisani; J Monti; M de L Álvarez; D E A Francés; M T Ronco; C E Carnovale
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

6.  Study of the pharmacokinetic changes of Tramadol in diabetic rats.

Authors:  Hoda Lavasani; Behjat Sheikholeslami; Yalda H Ardakani; Mohammad Abdollahi; Lida Hakemi; Mohammad-Reza Rouini
Journal:  Daru       Date:  2013-03-07       Impact factor: 3.117

7.  Effects of Diabetes Mellitus on the Disposition of Tofacitinib, a Janus Kinase Inhibitor, in Rats.

Authors:  Eun Hye Gwak; Hee Young Yoo; So Hee Kim
Journal:  Biomol Ther (Seoul)       Date:  2020-07-01       Impact factor: 4.634
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.